Status : Published Published On : Feb, 2024 Report Code : VRHC1249 Industry : Healthcare Available Format : Page : 220
2025
2030

Global Clinical Decision Support System (CDSS) Market – Analysis and Forecast (2025-2030)

Industry Insight by Product (Integrated CDSS and Standalone CDSS), by Mode of Delivery (On Premise Delivery Model, Web-Based Delivery Model, and Cloud-Based Delivery Model), by Model (Knowledge Based CDSS and Non-Knowledge Based CDSS), by Component (Hardware, Software, and Services), by Application(Drug-Drug Interactions, Drug Allergy Alerts, Clinical Reminders, Clinical Guidelines, Drug Dosing Support, and Others), by Level of Interactivity (Active CDSS and Passive CDSS), by Settings (Inpatient Settings and Ambulatory Care Settings), and Geography (U.S., Canada, Germany, U.K., France, China, Japan, India, and Rest of the World)

Industry Overview

The Global CDSS (clinical decision support system) market size is expected to grow from USD 1.17 billion in 2023 to USD 2.78 billion by 2030 at a CAGR of 6.5% during the forecast period ranging from 2025 to 2030.

CDSS refers to the software used extensively in healthcare IT to make informed and precise decisions by matching the characteristics of the patients to the knowledge base. One specific solution is the mHealth-based clinical decision support system that helps in monitoring the health of the patients along with the differences in symptoms. In addition, these solutions also help the patients to adhere to or comply with their medication schedules and stick to the changes in their routines, if any.

Clinical Decision Support System (CDSS) Market Highlights

The growth of the Global CDSS (clinical decision support system) market is attributed to the high adoption in hospitals and healthcare facilities to handle the huge inflow of critically ill patients despite capacity restraints and shortage of staff. It is also the result of significant advancements in these systems in recent times, which allow for informed decisions in a quick time to provide better patient outcomes and reduce healthcare costs. Government initiatives and regulations to promote CDSS and enhance care quality, patient safety, and interoperability have also prompted higher investments by healthcare organizations and promoted market growth.

Challenges to market growth, however, are the strict regulatory guidelines of the FDA that oversee the CDSS industry. Opportunities for growth in this market are presented by the market players prioritizing geographic expansion to tap into the new markets, higher investments in manufacturing facilities and R&D centers in new locations, and acquiring companies in different countries to foster revenue and market growth.

Market Segmentation

The Global CDSS (clinical decision support system) market is divided by product into integrated CDSS and standalone CDSS. Out of these two segments, the integrated CDSS segment is expected to contribute to a larger share of the market during the forecast period due to the growing demand for more effective clinical decision support system solutions with association and information exchange functions.

Insight by Mode of Delivery

The Global CDSS (clinical decision support system) market is divided into different modes of delivery: an on-premise delivery model, a web-based delivery model, and cloud-based delivery model segments. Out of these three segments, the cloud-based mode of delivery will witness higher growth during the forecast period due to higher adoption and the wide range of benefits offered by these support systems over on-premise and web-based CDSS. This is because the processing units of these cloud-based models are located on remote servers in several data centers across the world. This makes them less vulnerable to cyberattacks.

Insight by Model

The Global CDSS (clinical decision support system) market is divided by models into knowledge-based CDSS and non-knowledge-based CDSS segments. Out of these two segments, the knowledge-based CDSS segment will dominate the market. It will grow at a higher CAGR during the forecast period due to the ability to offer better clinical outcomes. Furthermore, these systems can be integrated into clinical workflow to facilitate proceedings and are also less prone to errors than non-knowledge-based systems.

Insight by Component

The Global CDSS (clinical decision support system) market is divided by components into hardware, software, and services. Out of these three segments, the CDSS services segment is expected to grow more during the forecast period due to the timely update of the software and the accessible knowledge base. Since advanced access to the latest and most accurate data is expensive, the revenue generation of this particular segment is expected to be higher during the projected period.

Insight by Application

The Global CDSS (clinical decision support system) market is divided by applications into drug-drug interactions, drug allergy alerts, clinical reminders, clinical guidelines, drug dosing support, and other segments. Out of all these segments, the drug allergy segment is expected to dominate the market. However, the rise in the number of drug combinations will also fuel the growth of the drug dosing support segment over the forecast period.

Insight by Level of Interactivity

The Global CDSS (clinical decision support system) market is divided by the varied levels of interactivity into active CDSS and passive CDSS. Out of these two segments, the active CDSS is expected to grow more because it uses a knowledge base and reasoning engine for comparing existing patient data with programming guidelines and protocols. This provides more precise information to healthcare providers and physicians, thereby helping them to make better decisions.

Insight by Settings

The Global CDSS (clinical decision support system) market is divided by settings into inpatient settings and ambulatory care settings segments. Out of these two segments, the inpatient settings segment is expected to grow at a higher CAGR during the forecast period due to cost-effectiveness and its ability to facilitate the healthcare system through clinical interventions. This, in turn, helps in reducing inpatient hospitalizations and repeat testing and also in suggesting cheaper drug options.

Global Clinical Decision Support System (CDSS) Market Report Coverage

Report Metric

Details

Historical Period

2018 - 2023

Base Year Considered

2024

Forecast Period

2025 - 2030

Market Size in 2023

U.S.D.  1.17 Billion

Revenue Forecast in 2030

U.S.D.  2.78 Billion

Growth Rate

6.5%

Segments Covered in the Report

By Product, By Mode of Delivery, By Model, By Component, By Application, By Level of Interactivity and By Settings

Report Scope

Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling

Regions Covered in the Report

North America, Europe, Asia-Pacific, Middle East, South America and Rest of the World

Industry Dynamics

Industry Trends

One of the most significant trends in the CDSS industry is the rising government rules and regulations that require the adoption of HIT solutions. In addition, there has also been a significant rise in the use of CDSS-enabled EHRs and the rise in collaborations with stakeholders. There has also been a growing adoption of mHealth technology and big data within the industry. Some other notable trends are the growing prevalence of medication errors and the rising traction of cloud computing, which offers higher scalability and flexibility along with easy access from any location or device.

Growth Drivers

The most significant growth factor of the global CDSS market is the growing aging population as well as the significant progress in the healthcare sector in emerging countries. Other than that, the growing importance of data-driven technologies and the rise in the number of emergency visits to hospitals promote the development and growth of the CDSS market size worldwide. The rise in the incidence of medication error has encouraged increased adoption of electronic health records (EHRs) for easy access to patient history by healthcare providers. This involves a huge amount of data, and CDSS helps in managing and providing real-time clinical decision support, thereby promoting market growth. Moreover, progress in AI and ML technology and its adoption has transformed the CDSS market, offering better functionalities to fuel its market growth, just like the higher adoption of personalized medicine has.

Challenges

Implementation of CDSS involves high investment, a significant drawback that hinders the growth of the global CDSS market. Moreover, less reliability, a shortage of skilled professionals to handle these systems, and the reluctance of clinicians to use mobile CDSS also hinder market growth. Furthermore, the lack of interoperability between CDSS and EHR may result in issues in compatibility, data-sharing protocols, and standards, causing disruptions that hinder the growth of the market.

Opportunities

Growth opportunities to the global CDSS market are offered by the implementation of healthcare information technology (HCIT) by the government and the rise in government healthcare expenditure. Also, rapid tech developments and the availability of skilled IT experts in developing Asian countries like India and China, as well as the ability to integrate CDSS into the overall functioning mechanism of a hospital and collaboration with precision medicine providers, create further growth opportunities.

Geographic Overview

North America is expected to contribute a larger share of the market due to higher investment in healthcare IT solutions and growing awareness among patients.

The Asia Pacific market will also grow at a high CAGR due to rising incidences of chronic diseases and healthcare expenditure and increasing investments in HIT (healthcare information technology).

Competitive Insight

There are diversified local, regional, and international players in the clinical decision support system market. However, some large international players dominate the market due to their brand image and market influence. Market participants continue to pay attention to acquisitions, mergers, provision of customized solutions, and expansion of the untapped business market. In addition, the company also invests a lot of money in the development of new products, and new platforms, with enhanced and improved features as part of its market entry strategy.

Some of the major players in the global CDSS market include Cerner Corporation, Epic Systems Corporation, Medical Information Technology, Inc., Wolter Kluwer N.V., Zynx Health Incorporated, Elsevier, IBM Watson Health, Allscripts Healthcare, LLC, Siemens Healthcare GmbH, and McKesson Corporation.

Epic Systems Corporation is an American privately held healthcare software company. Epic is a cloud-based EHR built for hospitals with the functionality to handle the day-to-day operations of a practice, including patient medical records. 

Medical Information Technology, Inc., shortened to Meditech, is a privately held Massachusetts-based software and service company that develops and sells information systems for health care organizations. 

Recent Developments by Key Players

Wolter Kluwer N.V. has launched two resources to advance simulation in nursing education and help nursing students build actionable skills from classroom knowledge.

Independent Pharmacy Cooperative (IPC) - a leading group purchasing organization of community pharmacies partnered with McKesson (a diversified healthcare leader and pharmaceutical distribution wholesaler). The agreement, marks a significant milestone to empower companiy's member pharmacies.

The Clinical Decision Support System (CDSS) Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.

Segments Covered in the Report

  • By Product 
    • Integrated CDSS
    • Standalone CDSS
  • By Mode of Delivery
    • On-Premise Delivery Model
    • Web-Based Delivery Model
    • Cloud-Based Delivery Model
  • By Model 
    • Knowledge-Based CDSS
    • Non-Knowledge Based CDSS
  • By Component
    • Hardware
    • Software
    • Services
  • By Application 
    • Drug-Drug Interactions
    • Drug Allergy Alerts
    • Clinical Reminders
    • Clinical Guidelines
    • Drug Dosing Support
    • Others
  • By Level of Interactivity 
    • Active CDSS
    • Passive CDSS
  • By Settings
    • Inpatient Settings
    • Ambulatory Care Settings

Region Covered in the Report

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World (RoW)
    • Brazil
    • Saudi Arabia
    • South Africa
    • U.A.E.
    • Other Countries

 

Clinical Decision Support System (CDSS) Market Size and Market Analysis

Source: VynZ Research

Frequently Asked Questions

The Asia Pacific CDSS market is anticipated to grow at a high CAGR during the forecast period owing to an increase in the geriatric population, improved government legislation, an increase in incidences of chronic diseases, increasing investments in HIT (healthcare information technology), and increasing healthcare expenditure in the region.
The COVID-19 pandemic has intensified the use of CDSS by the hospitals and health systems are there is a huge inflow of critically ill patients, shortage of staff, and capacity restraints. This has reduced the time for decision-making due to unmatched stress. Thus, resulting in the advancement of the CDSS market globally.
Some of the major players in the global CDSS market include Cerner Corporation, Epic Systems Corporation, Medical Information Technology, Inc., Wolter Kluwer N.V., Zynx Health Incorporated, Elsevier, IBM Watson Health, Allscripts Healthcare, LLC, Siemens Healthcare GmbH, and McKesson Corporation.
Growing focus on quality care, increase in geriatric population suffering from chronic diseases minimizing medication errors, implementation of government regulations, increase in adoption of mHealth solutions, and integration with reliable technical solutions like EHR are the key factors stimulating the growth of the market.
The global CDSS (clinical decision support system) market size is anticipated to grow at a CAGR of 6.5% and in terms of value from USD 1.13 billion in 2023 to USD 2.78 Billion by 2030.

Purchase Options

Research Methodology

  •  Desk Research / Pilot Interviews
  •  Build Market Size Model
  •  Research and Analysis
  •  Final Deliverabvle

Connect With Our Sales Team

Key Takeaways